Search - tctmd.com

Displaying 41 - 60 of 287

Sort: Relevancy | Date

Presentation NY Valves 2025

Outcomes of Transcatheter Tricuspid Valve Replacement Across Devices: A Comprehensive Pooled Analysis

Presenter: Taha Hatab

June 26, 2025

Presentation NY Valves 2025

30-Day TRINITY Trial Outcomes in Large-Anatomies Patients Using LuX-Valve Plus Transjugular Tricuspid Valve Replacement System

Presenter: Thomas Elie Modine

June 26, 2025

Presentation NY Valves 2025

Initial Results From the International Multi-Center Internal Jugular (IJ) Evoque Valve Registry

Presenter: Brian P. O'Neill

June 26, 2025

Presentation NY Valves 2025

Right Valve, Wrong Fix: Decoding Persistent Tricuspid Regurgitation Post Valve-in-Ring

Presenter: Abdelrahman Ahmed

June 26, 2025

Presentation NY Valves 2025

Predicting Futility in Tricuspid Valve Interventions

Presenter: Volker Rudolph

June 26, 2025

Presentation NY Valves 2025

Is There a Rebound Favoring Surgery for Severe TR… Or Is RHF Still an Exclusion

Presenter: Robert L. Smith

June 26, 2025

Presentation NY Valves 2025

Tricuspid Valve-In-Evoque

Presenter: Jubin Joseph

June 26, 2025

Presentation NY Valves 2025

What Is the Role of Heterotopic Valves for Refractory TR Patients

Presenter: Alexander Lauten

June 26, 2025

Presentation NY Valves 2025

Trends and Outcomes of Cardiogenic Shock in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair: A U.S. National Analysis

Presenter: Salman Zahid

June 26, 2025

Presentation NY Valves 2025

Does Right Heart Ventricular Function Impact Device Choices in TTVI?

Presenter: Carlos E. Sanchez

June 26, 2025

Presentation NY Valves 2025

Transcatheter Implantation of SAPIEN 3 Ultra Resilia Valve in Native Tricuspid Valve

Presenter: Curtiss T. Stinis

June 26, 2025

Presentation NY Valves 2025

Differential Mechanism of Annuloplasty for Functional Mitral Regurgitation Versus Functional Tricuspid Regurgitation

Presenter: Matthew Kazaleh

June 26, 2025

Presentation NY Valves 2025

Impact of Frailty on Outcomes After Transcatheter Edge-to-Edge Repair (TTEER) From the National Inpatient Sample 2021–2022

Presenter: Mustafa Shehzad

June 26, 2025

Presentation NY Valves 2025

Transcatheter Treatment of Tricuspid Regurgitation due to Dehiscence of a Surgical Ring: Combining Intra- and Para-Valvular Approaches

Presenter: Alan Wong

June 26, 2025

Presentation NY Valves 2025

The Importance of Hemodynamic Profiling (Including PV Loops)

Presenter: Michael I. Brener

June 26, 2025

Presentation NY Valves 2025

Intraprocedural Optimization of Tricuspid TEER

Presenter: Edwin Ho

June 26, 2025

Presentation NY Valves 2025

How Many Clinical Phenotypes?

Presenter: Dharam J. Kumbhani

June 26, 2025

Presentation NY Valves 2025

Concomitant vs. Staged Mitral and Tricuspid Edge-to-Edge Repair: The COMMITTEE Study

Presenter: Antonio Sisinni

June 26, 2025

Presentation NY Valves 2025

Treatment Implications of Tricuspid Regurgitation in Patients With Heart Failure With Reduced Ejection Fraction

Presenter: Mitsunobu Kitamura

June 26, 2025

Presentation NY Valves 2025

Redo Transcatheter Interventions: Recurrent Severe Tricuspid Regurgitation in a Patient With Prior ViV TTVR

Presenter: Amr Mohsen

June 26, 2025

Advertisement

Outcomes of Transcatheter Tricuspid Valve Replacement Across Devices: A Comprehensive Pooled Analysis

30-Day TRINITY Trial Outcomes in Large-Anatomies Patients Using LuX-Valve Plus Transjugular Tricuspid Valve Replacement System

Initial Results From the International Multi-Center Internal Jugular (IJ) Evoque Valve Registry

Right Valve, Wrong Fix: Decoding Persistent Tricuspid Regurgitation Post Valve-in-Ring

Predicting Futility in Tricuspid Valve Interventions

Is There a Rebound Favoring Surgery for Severe TR… Or Is RHF Still an Exclusion

Tricuspid Valve-In-Evoque

What Is the Role of Heterotopic Valves for Refractory TR Patients

Trends and Outcomes of Cardiogenic Shock in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair: A U.S. National Analysis

Does Right Heart Ventricular Function Impact Device Choices in TTVI?

Transcatheter Implantation of SAPIEN 3 Ultra Resilia Valve in Native Tricuspid Valve

Differential Mechanism of Annuloplasty for Functional Mitral Regurgitation Versus Functional Tricuspid Regurgitation

Impact of Frailty on Outcomes After Transcatheter Edge-to-Edge Repair (TTEER) From the National Inpatient Sample 2021–2022

Transcatheter Treatment of Tricuspid Regurgitation due to Dehiscence of a Surgical Ring: Combining Intra- and Para-Valvular Approaches

The Importance of Hemodynamic Profiling (Including PV Loops)

Intraprocedural Optimization of Tricuspid TEER

How Many Clinical Phenotypes?

Concomitant vs. Staged Mitral and Tricuspid Edge-to-Edge Repair: The COMMITTEE Study

Treatment Implications of Tricuspid Regurgitation in Patients With Heart Failure With Reduced Ejection Fraction

Redo Transcatheter Interventions: Recurrent Severe Tricuspid Regurgitation in a Patient With Prior ViV TTVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content